Abstract:Purpose - to evaluate the effectiveness of the use of the Ayurvedic phytocomposition Femicycle for the correction of stressful menstrual disorders (MD) in women of reproductive age. Materials and methods. Under observation were 209 women aged 18 to 35 years, of which 177 with stressful MD (the Group I) and 32 gynecologically, mentally and somatically healthy women (the Group of the control (GC). All examined patients of the Group I received vitamin - mineral complexes. The Group I included the Main group (n=91), in which women additionally used the Ayurvedic drug Femicycle, 1 capsule twice a day with meals for 6 months. Patients in the Comparison group (n=86) received only vitamin and mineral complexes. The level of perception of stress according to PSS-10 and the level of psychological stress according to PSM-25, the hormonal profile of peripheral blood serum was assessed. MD were assessed before and after the treatment. Results. The level of perception of stress with the help of PSS-10 in the Group I was 1.57 times higher than in the GC - 34.91±0.56 points vs. 22.21±0.86 points (p<0.01). The level of psychological stress according to PSM-25 in the Group I was 1.28 times higher relative to this indicator in the GC, respectively - 114.61±0.97 points vs. 89.75±3.49 points (p<0.01). Compared to women in the GC, women with stress-induced disorders of the MC had a lower level of luteinizing hormone, increased levels of follicle-stimulating hormone, adrenocorticotropic hormone, thyroid-stimulating hormone against the background of decreased levels of estradiol, free testosterone, androstenedione, dehydroepiandrosterone sulfate and increased levels of cortisol and 17(OH)-progesterone. In patients of the Group I, after stress, the appearance of scanty menstruation was observed in 13.56% of cases, excessive menstruation - in 18.08%, rare menstruation - in 57.06%, amenorrhea - in 12.99% and intermenstrual bleeding - in 11.86%. In women of the Group I, 67.23% of cases had manifestations of dysmenorrhea and 48.59% of premenstrual syndrome vs. 37.50% (OR=3.084; 95% CI: 1.565-7.471) and 25.00% (OR=2.39; 95% CI: 1.209-6.651) individuals of the GC. After 6 months from the start of treatment, in the Main group, compared to the Comparative group, scarce menstruation was recorded 8.47 times less often (OR=2.073; 95% CI: 0.013-0.886), excessive menstruation - by 9.52 times (OR=2.209; 95% CI: 0.012-0.767), rare menstruation - 8.82 times (OR=3.297; 95% CI: 0.024-0.288), amenorrhea - 6.35 times (OR=1.750; 95% CI: 0.018-1.257]), intermenstrual bleeding - 3.70 times (OR=1.680; 95% CI: 0.051-1.254), dysmenorrhea - 1.72 times (OR=3.331; 95% CI: 0.193-0.653]), premenstrual syndrome - 1.71 times (OR=2.343; 95% CI: 0.239-0.880). Conclusions. Ayurvedic phytocomposition Femicycle is an effective remedy and first choice drug for women of reproductive age in the treatment of stressful MD. The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of the participating institution. No conflict of interests was declared by the authors.

An innovative technology for natural raw materials processing and phytocomplex production of a functional purpose

Scientific approach to the production of functional food ingredients based on unconventional plant materials

Phytosterol Organic Acid Esters: Characterization, Anti-Inflammatory Properties and a Delivery Strategy to Improve Mitochondrial Function

Novel compositions for use in pre-menopausal and menopausal women for providing improved nutritional supplement and / or relief of menopausal symptoms

Effects of the PREMEN-CALM® in the Management of the Premenstrual Syndrome: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

An Effective Treatment of Perimenopausal Syndrome by Combining Two Traditional Prescriptions of Chinese Botanical Drugs

Styphnolobium japonicum Fruit and Germinated Soybean Embryo Complex Extract for Postmenopausal-Symptom Relief

Role of Inflammation, Oxidative Stress, and Mitochondrial Changes in Premenstrual Psychosomatic Behavioral Symptoms with Anti-Inflammatory, Antioxidant Herbs, and Nutritional Supplements

THE INVESTIGATION OF PHARMACOLOGICAL PROPERTIES OF VAGINAL GEL WITH RESVERATROL AND HYALURONIC ACID IN CONDITIONS OF EXPERIMENTAL HYPOESTROGENIC STATE IN RATS

Phytotherapeutic approach for conquering menopausal syndrome and osteoporosis

Effective therapy for menopausal syndrome without hormones and side effects. Illusion? Reality!

Individualization of approaches to managing patients during menopausal transition

Menopausal transition. Is it possible to delay the prescription of menopausal hormone therapy?

[Clinical evaluation of the efficacy of innovative spread of a given fatty acid composition enriched by adaptogens]

Complex Extract of Polygonatum sibiricum and Nelumbinis semen Improves Menopause Symptoms via Regulation of Estrogen Receptor Beta in an Ovariectomized Rat Model

Green gram soup and barley porridge as dietary interventions for management of premenstrual syndrome in adolescent girl: A case report

Biologically Active Complex Based on Fermented Fiber to Normalize and Ensure the Vital Microflora Activity

[Analysis of the effects on menopausal symptoms, quality of Life, and cardiovascular risk factors of five different therapy in women at early stage of menopause]

Online positive-oriented counseling, taking vitamin D3 tablet, online lifestyle modification training on premenstrual syndrome: a 3-armed randomized clinical trial

Ayurvedic drug Femicycle as the first line of therapy for stressful menstrual disorders in women of reproductive age

Estrogen receptor β-selective phytoestrogenic formulation prevents physical and neurological changes in a preclinical model of human menopause